Abivax stock crashed Monday after several patients developed cancer following a study of its ulcerative colitis treatment.

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this 12-part journey ...

June 1 (Reuters) - Abivax said on Monday its experimental drug for patients with ulcerative colitis, a type of chronic inflammatory ​disease, met the main goal of a closely watched late-stage trial.

The treatment for ulcerative colitis and Crohn’s disease combines two already available drugs that worked better in clinical trials than either drug alone, researchers report.

Eugenia Uche-Anya, MD, MPH, gastroenterology fellow at Massachusetts General Hospital, discusses the results of the case and important points to keep in mind when treating patients with mild UC: ...

Michael Dolinger, MD,an assistant professor of pediatric gastroenterology at the Icahn School of Medicine and Mount Sinai Kravis Children's Hospital, discusses the baseline characteristics of the case ...

GLP-1 medications like Ozempic and Wegovy are popular. Learn about the safety, potential benefits, and GI risks of taking these drugs for people with ulcerative colitis.